NEWGENIVF GROUP LTD-A
NIVFNASDAQ🏆 #3934 by market capUS Equity
$550.00▼ $42.13 (−7.66%)
Simulated price1h—
24h▼ 7.7%
7d—
14d—
30d—
1y—
🏦Market Cap
$3M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
24.3%
Moderate
💵FCF Margin
—
⚖️P/S Ratio
1.0x
Cheap
Otter Score
44
Weak
No chart data available for NIVF.
Trading Snapshot
- Day Range
- $544.38 – $559.61
- 52-Week Range
- $0.56 – $2,052.00
- Volume
- $4.44B
- Avg Volume
- $3.33B
- Shares Outstanding
- 3.4M
- Next Earnings
- Sep 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $747,876
- P/E Ratio
- 0.4
- P/S Ratio
- 1.0x
- EPS (TTM)
- $3,483.96
- Dividend Yield
- —
Why Investors Own NIVF
- ✓High-growth profile — revenue up +20.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 74% gross margin and 16% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$3M▲ +17.6% YoY
Gross Margin (TTM)
74.1%▲ +2.5% YoY
Operating Income (TTM)
$677,019▲ +17.6% YoY
Free Cash Flow (TTM)
$459,196▲ +17.6% YoY
About NEWGENIVF GROUP LTD-A
A company profile for NEWGENIVF GROUP LTD-A isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
44/100
Analyst Price Target
ⓘAverage Target
$538.31
▼ −2.1% Downside
High Target$657.35
Low Target$444.74
Based on 13 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
NEWGENIVF GROUP LTD-A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift NIVF price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
NEWGENIVF GROUP LTD-A announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.